Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000225975 | SCV000288224 | benign | Baller-Gerold syndrome | 2025-01-23 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001582779 | SCV001820609 | likely benign | not provided | 2020-12-17 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV002257550 | SCV002527875 | likely benign | Hereditary cancer-predisposing syndrome | 2021-01-31 | criteria provided, single submitter | curation | |
Breakthrough Genomics, |
RCV001582779 | SCV005222952 | likely benign | not provided | criteria provided, single submitter | not provided | ||
KCCC/NGS Laboratory, |
RCV005235173 | SCV005881193 | benign | Rapadilino syndrome | 2025-02-01 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001582779 | SCV001930691 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001726065 | SCV001964918 | benign | not specified | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004541411 | SCV004772568 | benign | RECQL4-related disorder | 2019-07-09 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |